Monthly Archives: April, 2023

. This article covers the trend of smartphone sales decline amid pandemic-caused economic disruptions, new form factors being experimented by phone manufacturers, Apple's Fitness+ product and expansion of health features, Amazon discontinuing Halo product line, but succeeding in health field with Amazon Clinic, and acquisition of One Medical. Get the latest on the developments of Google, Apple and other tech companies with news from experienced journalist, Mark Gurman.

This JAMA Internal Medicine study reveals that an AI tool, ChatGPT, is capable of outperforming physicians in answering medical questions. Bearing an impressive 79% accuracy rate and more empathetic response than doctors, it is advocated to start carrying out phase one clinical trials of AI in healthcare. Can both AI tools and doctors answer correctly? Read this article to find out!

Santiago Valdarrama and his team have managed to combine OpenAI's ChatGPT artificial intelligence with Boston Dynamics' robot dog Spot, resulting in a video of the robot conversing with the AI. The video gained worldwide attention and showed Spot using Google's text-to-speech AI to answer queries concerning its mission and battery level. Valdarrama is a Machine Learning Engineer, currently employed by FlightViz, who works on solutions with artificial intelligence, machine learning and computer vision.

. OpenAI, a San Francisco-based AI startup, has seen its value soar to over $27 billion after successful fundraisings. Their popular AI chatbot, ChatGPT, has also resumed operations in Italy after a pause of one month imposed by authorities. Learn how the company complied with Italian data collection requests, plus exciting news of a business subscription & more!

Insider Discourse is offering a unique perspective into intriguing stories that could affect our lives: from AI ending coding as we know it to 4-day workweek studies and Larry Page's wild designs from Kittyhawk, we're rethinking the way we live. We also explore MLM and weight-loss drug Ozempic. Delve into editor Hallam Bullock's deep investigations and get an insightful discourse about the day's issues!